{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:19:38Z","timestamp":1785291578028,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.euf.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T20:20:37Z","timestamp":1616098837000},"page":"498-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Tumor Size Predicts Muscle-invasive and Non\u2013organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8110-7341","authenticated-orcid":false,"given":"Claudia","family":"Coll\u00e0 Ruvolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nocera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Franziska","family":"Stolzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.03.003_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0010","article-title":"Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma","author":"Coll\u00e0 Ruvolo","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2021.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2021.03.003_bib0020","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.12.002","article-title":"Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma","volume":"37","author":"Petros","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2021.03.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.10.029","article-title":"Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States","volume":"36","author":"Singla","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2021.03.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4368943","article-title":"The influence of tumor size on oncologic outcomes for patients with upper tract urothelial carcinoma after radical nephroureterectomy","volume":"2016","author":"Su","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.euf.2021.03.003_bib0045","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bju.13463","article-title":"Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases","volume":"118","author":"Yan","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.03.003_bib0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11255-013-0533-9","article-title":"The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma","volume":"46","author":"Milenkovic-Petronic","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2021.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2021.03.003_bib0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MOU.0000000000000832","article-title":"Perioperative chemotherapy for upper tract urothelial carcinoma: show me the evidence","volume":"31","author":"Prad\u00e8re","year":"2021","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0070","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","article-title":"First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study","volume":"18","author":"Balar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2021.03.003_bib0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2021.03.003_bib0080","doi-asserted-by":"crossref","unstructured":"Califano G, Ouzaid I, Verze P, Hermieu J-F, Mirone V, Xylinas E. Immune checkpoint inhibition in upper tract urothelial carcinoma. World J Urol. In press. https:\/\/doi.org\/10.1007\/s00345-020-03502-7.","DOI":"10.1007\/s00345-020-03502-7"},{"key":"10.1016\/j.euf.2021.03.003_bib0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eururo.2020.04.008","article-title":"Re: Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"78","author":"Califano","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0090","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","article-title":"Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma","volume":"182","author":"Isbarn","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper urinary tract cancer: location is correlated with prognosis","volume":"48","author":"van der Poel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MOU.0b013e328363212b","article-title":"Renal mass size: concordance between pathology and radiology","volume":"23","author":"Kathrins","year":"2013","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.urology.2006.04.042","article-title":"Impact of discordant radiologic and pathologic tumor size on renal cancer staging","volume":"68","author":"Kanofsky","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.03.003_bib0110","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-5347(05)67022-X","article-title":"The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer trials","volume":"164","author":"van der Meijden","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.03.003_bib0115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.ju.0000055471.78783.ae","article-title":"Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder","volume":"169","author":"Bol","year":"2003","journal-title":"J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:51:20Z","timestamp":1762498280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2405456921000602"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.03.003","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Size Predicts Muscle-invasive and Non\u2013organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}